In this study, we examined the expressions of LATS1 and YAP1 in HCC cells treated with TGF-β1, and found that TGF-β1 inhibited the growth of HCC cells by activating the Hippo signaling pathway. Here, TGFB1 is linked to hepatocellular carcinoma.